Regen BioPharma Inc (RGBP)

[cvinvestor]

That's where it gets tricky. We've been expecting such news for months only to get the PR in January that they still hadn't clarified an agreed upon safety protocol with the FDA, with whom they had previously stated they had been on the phone with discussing such issues.

I haven't gone back to look, but I believe that was last year around October or possibly earlier. Which begs the question, "Why?" Why, after many months, were they not able to design even a safety test protocol that would meet FDA approval? Does it have to do with FDA not being sure or clear because of the newness of the field (if so, then why are others getting approvals to move forward?), or does it have to do with Koos & company?

That's the red flag side of all this - HemaX was on a previous timeline to have concluded Phase I human trials in 2015, but here we are in 2015 without even an established protocol for new safety tests as of Jan. That's why I had given up most hope. My renewed outlook, as stated, is in the Ichims whom I'm assuming have integrity (via the testimony of their life stories) and would not become employees under Koos if they knew RGBP was a sham/scam scheme with no realistic hope of success.

That's also why I believe NR2F6, which depends on C. Ichim 10 years of research in field and her brother's patent regarding CTCFL, which they say are such that parallel studies can advance both, are now at the forefront of RGBP moving forward and maybe bypassing HemaX on hold.

Either way, if my speculation is grounded, we should have clarity through one or more PRs by end of March-mid April.

And with Cavens on board, I would expect some type of PR update bi-monthly or monthly regarding RGBP developments in order to continue interest in the hope of bringing in money.

It's got to get better with 3 others working full time than with Koos alone.